← Insider buys
CRBP

Corbus Pharmaceuticals Holdings, Inc. · Healthcare

Chief Medical Officer Dominic Smethurst sold $51K of Corbus Pharmaceuticals Holdings, Inc.

Sold$50,601
$8.30Price
6,097Shares
−6%Stake

What CRBP did after the filing

Filed Mar 4, copier in the same day
The stock from Wed, Mar 4 close, $8.42
+20.4%
S&P 500, same days
+2.4%

Measured over 30 trading days, to the Apr 16 close.

Traded Mon, Mar 2. Filed Wed, Mar 4, 11:30 AM ET, during the session. Returns use the Mar 4 close and the Apr 16 close. Not investment advice.